Cullinan Therapeutics, Inc. (CGEM) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 361.41M | 386.76M | 342.24M | 275.91M | 317.77M | 414.67M | 592.04M | 677.8M | 445.72M | 480.19M | 476.71M | 498.24M |
| Cash & Short-Term Investments | 351.88M | 377.9M | 332.6M | 265.48M | 303.83M | 398.98M | 578.08M | 662.5M | 433.01M | 467.07M | 466.43M | 491.8M |
| Cash Only | 75.08M | 88.33M | 103.33M | 72.82M | 76.66M | 83M | 102.08M | 115.02M | 74.23M | 98.43M | 64.85M | 141.83M |
| Short-Term Investments | 276.8M | 289.56M | 229.26M | 192.66M | 227.17M | 315.97M | 475.99M | 547.47M | 358.78M | 368.63M | 401.58M | 349.96M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 3M | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 9.52M | 8.86M | 9.64M | 10.43M | 13.95M | 12.69M | 13.96M | 15.3M | 12.71M | 13.12M | 10.28M | 6.44M |
| Total Non-Current Assets | 41.58M | 61.62M | 141.89M | 244.42M | 261.91M | 207.16M | 61.22M | 3.42M | 3.71M | 3.99M | 18M | 23.75M |
| Property, Plant & Equipment | 2.78M | 3.05M | 1.53M | 1.75M | 2.16M | 2.35M | 2.78M | 2.96M | 3.25M | 3.53M | 3.99M | 4.66M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 38.5M | 58.27M | 140M | 242.3M | 259.39M | 204.44M | 57.98M | 0 | 0 | 0 | 13.54M | 18.63M |
| Other Non-Current Assets | 297K | 297K | 361K | 367K | 366K | 366K | 460K | 460K | 460K | 459K | 459K | 459K |
| Total Assets | 402.98M | 448.37M | 484.13M | 520.33M | 579.68M | 621.82M | 653.25M | 681.22M | 449.43M | 484.18M | 494.71M | 521.98M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -30.48% | -27.89% | -25.89% | -23.62% | 28.98% | 28.43% | 32.05% | 30.51% | -12.73% | -13.71% | -19.85% | -21.77% |
| Total Current Liabilities | 35.15M | 37.74M | 32.76M | 28.06M | 27.35M | 30.65M | 24.2M | 23.48M | 21.93M | 28.14M | 23.44M | 19.68M |
| Accounts Payable | 2.51M | 841K | 1.72M | 2.46M | 3.4M | 1.68M | 2.12M | 1.55M | 3.71M | 2.49M | 951K | 2.49M |
| Days Payables Outstanding | 1.91K | - | - | - | - | - | - | 3.11K | 3.71K | 2.06K | - | - |
| Short-Term Debt | 725K | 780K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.92M | 1.89M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 31.92M | 36.12M | 8.89M | 19.39M | 2.79M | 1.44M | 14.96M | 16.6M | 3.98M | 7.9M | 1.58M | 4.14M |
| Current Ratio | 10.28x | 10.25x | 10.45x | 9.83x | 11.62x | 13.53x | 24.46x | 28.87x | 20.33x | 17.07x | 20.33x | 25.32x |
| Quick Ratio | 10.28x | 10.25x | 10.45x | 9.83x | 11.62x | 13.53x | 24.46x | 28.87x | 20.33x | 17.07x | 20.33x | 25.32x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.66M | 1.9M | 0 | 125K | 493K | 849K | 1.19M | 1.52M | 1.84M | 2.15M | 2.45M | 2.73M |
| Long-Term Debt | 1.66M | 1.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 125K | 493K | 849K | 1.19M | 1.52M | 1.84M | 2.15M | 2.45M | 2.73M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 36.81M | 39.64M | 32.76M | 28.18M | 27.84M | 31.5M | 25.39M | 25M | 23.77M | 30.29M | 25.89M | 22.41M |
| Total Debt | 2.38M | 2.68M | 1.19M | 1.52M | 1.84M | 2.15M | 2.45M | 2.73M | 3.17M | 3.59M | 5.92M | 6.27M |
| Net Debt | -72.7M | -85.65M | -102.15M | -71.3M | -74.81M | -80.85M | -99.64M | -112.29M | -71.06M | -94.84M | -58.93M | -135.56M |
| Debt / Equity | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 366.17M | 408.73M | 451.37M | 492.15M | 551.84M | 590.33M | 627.86M | 656.22M | 425.67M | 453.89M | 468.82M | 499.57M |
| Equity Growth % | -33.65% | -30.76% | -28.11% | -25% | 29.64% | 30.06% | 33.92% | 31.36% | -12.35% | -15.16% | -20.01% | -17.37% |
| Book Value per Share | 6.19 | 6.90 | 7.65 | 8.34 | 9.37 | 10.08 | 10.76 | 11.92 | 9.90 | 10.61 | 10.97 | 12.50 |
| Total Shareholders' Equity | 366.17M | 408.73M | 451.37M | 492.15M | 551.84M | 590.33M | 627.86M | 656.22M | 425.67M | 453.7M | 468.82M | 499.57M |
| Common Stock | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 4K | 4K | 4K | 4K |
| Retained Earnings | -637.78M | -588.12M | -537.41M | -486.8M | -416.74M | -368.24M | -320.59M | -280.03M | -238M | -200.86M | -177.05M | -137.87M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 127K | 1.02M | 973K | 607K | 505K | -133K | 970K | -476K | -331K | -129K | -1.05M | -1.63M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 192K | 0 | 0 |